UrviAjayShahMD

PubMed

• Unscheduled healthcare interactions in multiple myeloma patients receiving T cell redirection therapies.
  Anna J Howard, Isabel Concepcion, Alice X Wang, Issam S Hamadeh, Malin L Hultcrantz, Sham Mailankody, Carlyn Rose Tan, Neha Korde, Alexander M Lesokhin, Hani Hassoun, ...> ;Blood Advances. 2024 Apr 12
• Patterns of CRS with Teclistamab in Relapsed/Refractory Multiple Myeloma patients with Prior T-Cell Redirection Therapy.
  Issam S Hamadeh, Tala Shekarkhand, Colin Joseph Rueda, Ross S Firestone, Alice X Wang, Neha Korde, Malin L Hultcrantz, Alexander M Lesokhin, Sham Mailankody, Hani Hass...> ;Blood Advances. 2024 Apr 10
• 1 citations
  CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma.
  Ross S Firestone, Devin McAvoy, Tala Shekarkhand, Edith Serrano, Issam Hamadeh, Alice Wang, Menglei Zhu, Wei Ge Qin, Dhwani Patel, Carlyn R Tan, Malin Hultcrantz, Sham...> ;Blood Advances. 2024 Apr 9
• Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma.
  Irene M Ghobrial, Nicole Gormley, Shaji K Kumar, Maria-Victoria Mateos, P Leif Bergsagel, Marta Chesi, Madhav V Dhodapkar, Angela Dispenzieri, Rafael Fonseca, Gad Getz...> ;Blood Cancer Discovery. 2024 Mar 4
• Comparison of Infectious Complications with BCMA-directed Therapies in Multiple Myeloma.
  Lesokhin, A., Nath, K., Shekarkhand, T., Nemirovsky, D., Derkach, A., Costa, B., Nishimura, N., Farzana, T., Rueda, C., Chung, D., Landau, H., Lahoud, O., Scordo, M., ...> ;Research Square. 2024 Feb 7
• 3 citations
  Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups.
  Urvi A Shah, Erin Moshier, Andriy Derkach, Yuanhui Huang, Sham Mailankody, Carlyn R Tan, Kylee Maclachlan, Malin Hultcrantz, Neha Korde, Hani Hassoun, Santiago Thibaud...> ;Blood Advances. 2024 Jan 9
• Pre-diagnosis dietary patterns and risk of multiple myeloma in the NIH-AARP diet and health study.
  Parikh, R., Francesca Castro, Richa Parikh, Jelyn C Eustaquio, Andriy Derkach, Janine M Joseph, Alexander M Lesokhin, Saad Z Usmani, Urvi A Shah> ;Leukemia. 2024 Feb 1
• Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse population.
  Tang, L., Lesokhin, A., Landgren, O., Usmani, S., Moysich, K., Shah, U., Joseph, J., McCann, S., Hillengass, J.> ;Blood Advances. 2024 Feb 13
• 2 citations
  Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens.
  Francesco Maura, Eileen M Boyle, David Coffey, Kylee Maclachlan, Dylan Gagler, Benjamin Diamond, Hussein Ghamlouch, Patrick Blaney, Bachisio Ziccheddu, Anthony Cirrinc...> ;Nature Cancer. 2023 Dec 1
• Impact of race and ethnicity on early mortality in multiple myeloma: a SEER analysis.
  John X Wei, Aditi Shastri, R Alejandro Sica, Ioannis Mantzaris, Noah Kornblum, Urvi Shah, Murali Janakiram, Kira Gritsman, Amit Verma, Mendel Goldfinger, Dennis Cooper...> ;Haematologica. 2023 Oct 26
• Pre-Diagnosis Dietary Patterns and Risk of Multiple Myeloma in the NIH-AARP Diet and Health Study.
  Francesca Castro, Jelyn C Eustaquio, Andriy Derkach, Janine M Joseph, Alexander M Lesokhin, Saad Z Usmani, Urvi A Shah, Parikh, R.> ;Medrxiv. 2023 Sep 23
• Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma.
  Carlyn Rose Tan, Andriy Derkach, David Nemirovsky, Amanda Ciardiello, Benjamin Diamond, Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Urvi Shah, Kylee Maclachlan, D...> ;Blood Cancer Journal. 2023 Jul 25
• 2 citations
  Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma.
  Abdul-Hamid Bazarbachi, Daniel Reef, Hiba Narvel, Riya Patel, Rama Al Hamed, Sindhu Vikash, Karun Neupane, Eleftheria Atalla, Astha Thakkar, Shafia Rahman, Urvi Shah, ...> ;Clinical Hematology International. 2023 Jun 1
• 3 citations
  Personal and Planetary Health-The Connection With Dietary Choices.
  Urvi A Shah, Gia Merlo> ;JAMA. 2023 Jun 6
• 5 citations
  Imaging modalities for measuring body composition in patients with cancer: opportunities and challenges.
  Urvi A Shah, Tarah J Ballinger, Rusha Bhandari, Christina M Dieli-Cornwright, Kristin A Guertin, Elizabeth A Hibler, Faiza Kalam, Ana Elisa Lohmann, Joseph E Ippolito> ;Journal of the National Cancer Institute. Monographs. 2023 May 4
• 7 citations
  Dietary and microbiome evidence in multiple myeloma and other plasma cell disorders.
  Urvi A Shah, Francesca Castro, Matteo Bellone, Alexander M Lesokhin, Parikh, R., Richa Parikh> ;Leukemia. 2023 May 1
• 1 citations
  Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: a prospective observational cohort ...
  Neha Korde, Elizabet Tavitian, Donna Mastey, Joseph Lengfellner, Gil Hevroni, Andrew Zarski, Meghan Salcedo, Sham Mailankody, Hani Hassoun, Eric L Smith, Malin Hultcra...> ;Eclinicalmedicine. 2023 Mar 1
• 1 citations
  Bortezomib, Lenalidomide and Dexamethasone (VRd) vs Carfilzomib, Lenalidomide and Dexamethasone (KRd) as Induction Therapy in Newly Diagnosed Multiple Myeloma.
  Carlyn Rose Tan, Andriy Derkach, David Nemirovsky, Amanda Ciardiello, Benjamin Diamond, Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Urvi Shah, Kylee Maclachlan, D...> ;Research Square. 2023 Feb 24
• 5 citations
  Extreme body mass index and survival in newly diagnosed multiple myeloma patients.
  Urvi A Shah, Karissa Whiting, Sean Devlin, Rachel Ershler, Bindu Kanapuru, David J Lee, Sabrin Tahri, Thomas Gwise, Even H Rustad, Sham Mailankody, Alexander M Lesokhi...> ;Blood Cancer Journal. 2023 Jan 12
• 1 citations
  Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach.
  Matthew J Pianko, Timothy Tiutan, Andriy Derkach, Jessica Flynn, Steven P Salvatore, Insara Jaffer-Sathick, Adriana C Rossi, Oscar Lahoud, Malin Hultcrantz, Urvi A Sha...> ;American Journal of Hematology. 2023 Mar 1
• 22 citations
  Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy.
  Oliver Van Oekelen, Karthik Nath, Tarek H Mouhieddine, Tasmin Farzana, Adolfo Aleman, David T Melnekoff, Yogita Ghodke-Puranik, Gunjan L Shah, Alexander Lesokhin, Serg...> ;Blood. 2023 Feb 16
• A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy.
  Karthik Nath, Tala Shekarkhand, Meghan Salcedo, Andriy Derkach, Siobhan Rueda, Aisara Chansakul, Malin Hulcrantz, Neha Korde, Urvi A Shah, Carlyn Tan, David J Chung, O...> ;Leukemia & Lymphoma. 2022 Dec 1
• 85 citations
  GPRC5D-Targeted CAR T Cells for Myeloma.
  Sham Mailankody, Sean M Devlin, Jonathan Landa, Karthik Nath, Claudia Diamonte, Elizabeth J Carstens, Douglas Russo, Romany Auclair, Lisa Fitzgerald, Briana Cadzin, Xi...> ;The New England Journal of Medicine. 2022 Sep 29
• 13 citations
  Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets.
  Urvi A Shah, Kylee H Maclachlan, Andriy Derkach, Meghan Salcedo, Kelly Barnett, Julia Caple, Jenna Blaslov, Linh Tran, Amanda Ciardiello, Miranda Burge, Tala Shekarkha...> ;Clinical Cancer Research. 2022 Dec 1
• Myeloma precursor disease (MGUS) among rescue and recovery workers exposed to the World Trade Center disaster.
  Rachel Zeig-Owens, David G Goldfarb, Benjamin J Luft, Xiaohua Yang, Kazunori Murata, Lakshmi Ramanathan, Katie Thoren, Sital Doddi, Urvi A Shah, Alexandra K Mueller, C...> ;Blood Cancer Journal. 2022 Aug 22
• Join now to see all

Journal Articles

• Cancer and Coronavirus Disease 2019 (COVID-19)—Facing the “C Words”  
  Urvi Shah, MD, JAMA Oncology

Abstracts/Posters

• Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Multiple Myeloma Patients Treated with Lenalidomide Maintenance Therapy: A Clinical and Correlative Ph...
  Urvi A Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Weekly Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab (wKRd-D) Combination Therapy Provides Unprecedented MRD Negativity Rates in Newly Diagnosed Multiple My...
  Urvi A Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Conventional Chemotherapy Treatment Induces Unique Patterns of Clonal Evolution in a North American Adult T Cell Leukemia/Lymphoma Cohort
  Urvi A Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• MALDI-TOF Mass Spectrometry in Serum for the Follow-up of Newly Diagnosed Multiple Myeloma Patients Treated with Daratumumab-Based Combination Therapy
  Urvi A Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Effect of Active Hepatitis C Infection in Relapse-Free Survival Among Patients with HIV_Related Diffuse Large B_Cell Lymphoma
  Urvi A Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Multiple Myeloma Patients Treated with Lenalidomide Maintenance Therapy: A Clinical and Correlative Ph...
  Urvi A Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• VTE Rates and Safety Analysis of Newly Diagnosed Multiple Myeloma Patients Receiving Carfilzomib-Lenalidomide-Dexamethasone (KRD) with or without Rivaroxaban Prophylaxis
  Urvi A Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• The Rising Number of Adult T Cell Leukemia Lymphoma (ATLL) Cases in Non-Hispanic Blacks and Its Association with Poor Outcomes 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Differentiating Lung Involvement in Adult T-Cell Leukemia Lymphoma (ATLL) Versus HTLV Infection: Results from a Large Single-Center Cohort with Implications for Stagin... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018